Second, they found an overexpression of TrxR1 in hypoxic myeloma cells RPMI8226 and U266 resistant to bortezomib, suggesting a possible involvement of this enzyme in the hypoxia‐induced bortezomib resistance. Here, TXNRD1 is linked to plasma cell myeloma.